Showing results (231-240 of 303) with videos related to
Sort By:
Pageof 31
Journal of Virology|November 6, 2009
The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell deathEric C Freundt, Li Yu, Cynthia S Goldsmith, et al.Proceedings of the National Academy of Sciences of the United States of America|July 15, 2015
Structures of complexes formed by H5 influenza hemagglutinin with a potent broadly neutralizing human monoclonal antibodyXiaoli Xiong, Davide Corti, Junfeng Liu, et al.Nature|September 30, 2015
The soft palate is an important site of adaptation for transmissible influenza virusesSeema S Lakdawala, Akila Jayaraman, Rebecca A Halpin, et al.The Journal of Infectious Diseases|January 19, 2013
A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trialAnna P Durbin, Beth D Kirkpatrick, Kristen K Pierce, et al.Plos One|November 3, 2018
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trialKatherine V Houser, Galina V Yamshchikov, Abbie R Bellamy, et al.Journal of Hazardous Materials|January 23, 2025
Ultraviolet radiation vs air filtration to mitigate virus laden aerosol in an occupied clinical roomShane A Landry, Milan Jamriska, Vinay J Menon, et al.Elife|September 3, 2020
Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolutionJohn Huddleston, John R Barnes, Thomas Rowe, et al.Cell Reports|May 7, 2021
Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infectionJessie J-Y Chang, Daniel Rawlinson, Miranda E Pitt, et al.Nature Immunology|July 12, 2011
Systems biology of vaccination for seasonal influenza in humansHelder I Nakaya, Jens Wrammert, Eva K Lee, et al.Vaccine|June 9, 2020
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccinesPaul-Henri Lambert, Donna M Ambrosino, Svein R Andersen, et al.Pageof 31